Navigation Links
Potent Hepatitis C Virus Inhibitors Show Efficacy and Potential for Once Daily Dosing in Preclinical Studies
Date:11/1/2007

Data Presented at the 2nd Annual International Workshop on Hepatitis C

Resistance & New Compounds

WATERTOWN, Mass., Nov. 1 /PRNewswire/ -- Researchers from Enanta Pharmaceuticals today presented data on novel Hepatitis C protease inhibitors with potent antiviral activity in the cell-based replicon assay and favorable pre-clinical pharmacokinetic properties with the potential for once-daily dosing in humans.

The hepatitis C virus (HCV) increases a person's chances of developing chronic liver disease, and affects more than 170 million people worldwide. Current treatment options are not sufficient. Specifically targeted antiviral therapies for HCV, such as NS3/4a protease inhibitors, may have the potential to increase the proportion of patients in whom the virus can be eradicated.

The abstract, "Potent HCV protease inhibitors with the potential for once-daily dosing," was presented today in a session focused on protease inhibitors at 8:30 a.m. during the 2nd Annual International Workshop on Hepatitis C Resistance & New Compounds in Boston.

"These compounds have demonstrated remarkable potency in the antiviral replicon assay and favorable pre-clinical pharmacokinetic properties supporting the potential for once-daily dosing in humans," said Yat Sun Or, Senior Vice President, Research and Development of Enanta Pharmaceuticals. "These data demonstrate our commitment to the discovery of next-generation protease inhibitors that will enhance the treatment options for patients who are infected with hepatitis C."

Abbott and Enanta Pharmaceuticals formed a collaboration in 2006 to develop and commercialize HCV protease inhibitors. The partnership leverages Abbott's innovative work in the protease inhibitor field against the Human Immunodeficiency Virus (HIV) and leadership in the area of antiviral therapies and Enanta's core expertise in chemistry and drug discovery. The HCV NS 3/4A serine protease is the focus of
'/>"/>

SOURCE Enanta Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. New Information on the Potential of Plasmin Shared at ISTH Congress
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
5. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
6. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
7. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
8. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
9. Expert Opinion Highlights Avigens AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
10. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
11. New Study Shows That telmisartan has Greater Renoprotective Potential Thanlosartan in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)...  Columbia Laboratories, Inc. (Nasdaq: CBRX ) ... clinical trial manufacturing, and advanced analytical and consulting services ... participate at the upcoming Rodman & Renshaw 16 th ... New York . The Company will ... 2014 at the New York Palace Hotel. ...
(Date:8/27/2014)... LYNDHURST N.J. and NINGBO, China ... ("Amerigen") and the Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") ... regarding the development of generic pharmaceuticals, primarily targeting ... terms of the agreement, Amerigen and Menovo will jointly ... the United States . Menovo will be responsible ...
(Date:8/27/2014)... ON , Aug. 27, 2014 /CNW/ - Covalon Technologies ... technologies company, announces the following financial results for its third ... ended June 30, 2014: , Revenue of $1,291,378, ... year , Net loss for the quarter of $240,156 ... of the prior year For the nine ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... COVE, N.Y., Sept. 8 In response to the news ... issued a recall of its ASR product line after data ... five years after the initial procedure, Dr. Eugene S. Krauss, ... Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member ...
... the Indiana State Legislature,s Criminal Law and Sentencing Policy ... state can improve its policies for preventing the illegal ... leading cold and allergy medicines - for methamphetamine production. ... from requiring a prescription for currently accessible medicines like ...
Cached Medicine Technology:Patients Should Expect 'Long Life' from their Joint Replacements! 2Indiana State Legislators Seek Solutions to Combat Illegal Meth Production 2Indiana State Legislators Seek Solutions to Combat Illegal Meth Production 3
(Date:8/27/2014)... While many scientists are trying to prevent the ... autophagy, researchers at Virginia Commonwealth University Massey Cancer ... that causes the process to culminate in cell ... targets the p62 protein, which is often referred ... role in disposing unwanted cellular proteins during autophagy. ...
(Date:8/27/2014)... August 27, 2014 Representatives with ... Italy to its list of destinations for International Yoga ... Recharge Retreats, explained that the company chose Italy due ... for yoga teacher trainings since it's an easy flight ... for people traveling from all over Europe, UK, Africa, ...
(Date:8/27/2014)... Lighthouse Payment Services Inc ., a ... will exhibit its image-based lockbox services at the Independent ... in beautiful Lake Placid, New York from September ... held at the Lake Placid Convention Center and will ... in addition to a variety of vendors exhibiting the ...
(Date:8/27/2014)... Sugar Manufacturing in Australia ... in global supply and demand, which have contributed to ... industry derives a large share of its revenue from ... dynamics, with supply and prices being determined by larger ... Australian dollar for the majority of the past five ...
(Date:8/27/2014)... SCOTT Sports is excited to ... indoor mountain bike and BMX park. SCOTT will provide ... both adult and youth sizes for the park’s rental bike ... warehouse in Ogden, Utah, recently moved its U.S. headquarters from ... proud to be a partner with the Wasatch Bike Park, ...
Breaking Medicine News(10 mins):Health News:Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 3Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:SCOTT Sports to Sponsor Wasatch Indoor Bike Park 2
... MORGANTOWN, W.Va., April 17 Even though suicide outranks ... States, incomplete death certificates thwart healthcare policymakers who want ... Hispanic populations, a WVU study shows."The Institute ... commit suicide have been diagnosed with a mental disorder, ...
... LAUDERDALE, Fla., April 17 Former partner and accomplished ... & Scherer LLP as a partner.Genovese, most recently of ... has tried over 150 jury trials and has had ... Times and the Wall Street Journal. He is well ...
... 17 Recent economic events have led people to ... families. Many are feeling that it is time to ... and they are deciding to start their families now, ... cocooning is reflected in a growing number of couples ...
... 17 Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: ... its subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), ... for the purchase of all outstanding Ordinary Shares of ... now expire at 5:00 p.m., New York City time, ...
... April 30, 2009 - 9:00 a.m. ET HOPKINTON, Mass., ... CALP ) will conduct a conference call discussing ... a.m. ET on Thursday, April 30. Kevin Hrusovsky, ... Financial Officer, will host the call. Management will discuss ...
... 19 - April 25 HARRISBURG, Pa., April 17 ... for selflessly giving their time to help communities prepare ... to join those important efforts. "National Volunteer Week starts ... volunteers for generously sharing their time, energy and expertise ...
Cached Medicine News:Health News:Team Uncovers Discrepancy in Death Certificates Listing Suicide 2Health News:Veteran Medical Malpractice Litigator Gary S. Genovese Re-Joins Conrad & Scherer LLP 2Health News:Family Cocooning in the Face of Recession Leads to Expanded Business for Bay Area Fertility Doctor - Dr. Danielle Lane 2Health News:Sun Pharmaceutical Extends Tender Offer for Taro 2Health News:Sun Pharmaceutical Extends Tender Offer for Taro 3Health News:Caliper Life Sciences' First Quarter 2009 Financial Results Conference Call Notice 2Health News:PA Secretary of Health Recognizes Pennsylvania Volunteers; Urges Greater Citizen Involvement 2
Inoculum Broth...
... Molecular Biology Buffers are ready-to-use solutions ideal ... applications. Each reagent is prepared with 18 ... filter, and filled into sterile bottles., ... control standards to ensure lot-to-lot consistency. ...
1.2% Tryptone, 2.4% Yeast Extract, 0.4% Glycerol, with 100ml of 10x Phosphate buffer supplement (0190-01)....
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride....
Medicine Products: